Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease.

Zee RY, Hoh J, Cheng S, Reynolds R, Grow MA, Silbergleit A, Walker K, Steiner L, Zangenberg G, Fernandez-Ortiz A, Macaya C, Pintor E, Fernandez-Cruz A, Ott J, Lindpainter K.

Pharmacogenomics J. 2002;2(3):197-201.

2.

Candidate genetic markers and the risk of restenosis after coronary angioplasty.

Völzke H, Grimm R, Robinson DM, Wolff B, Schwahn C, Hertwig S, Motz W, Rettig R.

Clin Sci (Lond). 2004 Jan;106(1):35-42.

PMID:
12899665
3.

Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.

Hazra A, Chanock S, Giovannucci E, Cox DG, Niu T, Fuchs C, Willett WC, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):311-9. doi: 10.1158/1055-9965.EPI-07-0195.

4.

Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.

Monraats PS, Pires NM, Agema WR, Zwinderman AH, Schepers A, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Frants RR, Quax PH, van Vlijmen BJ, Atsma DE, van der Laarse A, van der Wall EE, Jukema JW.

Circulation. 2005 Oct 18;112(16):2417-25.

PMID:
16230497
5.

Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.

Ganesh SK, Skelding KA, Mehta L, O'Neill K, Joo J, Zheng G, Goldstein J, Simari R, Billings E, Geller NL, Holmes D, O'Neill WW, Nabel EG.

Pharmacogenomics. 2004 Oct;5(7):952-1004.

PMID:
15469413
6.

Lipid metabolism and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: role of cholesteryl ester transfer protein and paraoxonase/arylesterase.

Zee RY, Fernandez-Otiz A, Macaya C, Pintor E, Lindpaintner K, Fernandez-Cruz A.

J Thromb Haemost. 2003 Jun;1(6):1202-7.

7.

Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention.

Monraats PS, de Vries F, de Jong LW, Pons D, Sewgobind VD, Zwinderman AH, de Maat MP, 't Hart LM, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Frants RR, van der Laarse A, van der Wall EE, Wouter Jukema J.

Pharmacogenet Genomics. 2006 Oct;16(10):747-54.

PMID:
17001294
8.

Pre-existing anticardiolipin antibodies and development of restenosis after coronary balloon angioplasty: predictive value for a complicated course?

Niessner A, Hornykewycz S, Graf S, Nikfardjam M, Speidl WS, Probst P, Zorn G, Maurer G, Wojta J, Huber K.

Blood Coagul Fibrinolysis. 2004 Jun;15(4):311-6.

PMID:
15166916
9.

Genetic risk markers for post-angioplasty restenosis: what should we expect?

Green FR.

Clin Sci (Lond). 2004 Jan;106(1):1-2.

PMID:
12962537
10.

Genetic predictive factors in restenosis.

Monraats PS, R P Agema W, Jukema JW.

Pathol Biol (Paris). 2004 May;52(4):186-95. Review.

PMID:
15145131
11.

Prediction of infarction-related artery occlusion and multivessel disease in postinfarction angina.

Valenzuela LF, Vázquez R, Fournier JA, Cubero J, Maraví J, Cruz-Fernández JM, Kaski JC.

Int J Cardiol. 2007 Feb 14;115(3):381-5. Epub 2006 Jun 30.

PMID:
16814417
12.

Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty.

Hayashida K, Tanaka M, Morita H, Hayashi F, Inada T, Suzuki H, Sakamoto T, Katsuragawa M, Hibino H, Kambara H.

Heart Vessels. 2002 May;16(4):137-45.

PMID:
12224784
13.

Genetic markers of restenosis after coronary angioplasty and after stent implantation.

Petrovic D, Peterlin B.

Med Sci Monit. 2005 Apr;11(4):RA127-35. Epub 2005 Mar 24. Review.

PMID:
15795709
14.

Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.

Monraats PS, Kurreeman FA, Pons D, Sewgobind VD, de Vries FR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Huizinga TW, Eefting D, Quax PH, Frants RR, van der Laarse A, van der Wall EE, Jukema JW.

Genes Immun. 2007 Jan;8(1):44-50. Epub 2006 Nov 23.

PMID:
17122782
15.

Multi-SNP pharmacogenomic classifier is superior to single-SNP models for predicting drug outcome in complex diseases.

Petrovski S, Szoeke CE, Sheffield LJ, D'souza W, Huggins RM, O'brien TJ.

Pharmacogenet Genomics. 2009 Feb;19(2):147-52. doi: 10.1097/FPC.0b013e32831d1dfa.

PMID:
19077679
16.

Association between plasma pregnancy-associated plasma protein a and restenosis after percutaneous coronary angioplasty.

Li XP, Zhou SH, Tang JJ, Liu QM, Fang ZF, Hu XQ, Zhou T, Sheng XQ, Zhao SP.

Circ J. 2008 May;72(5):729-33.

17.

P27 and P53 gene polymorphisms and restenosis following coronary implantation of drug-eluting stents.

Tiroch K, Koch W, Mehilli J, Bottiger C, Schomig A, Kastrati A.

Cardiology. 2009;112(4):263-9. doi: 10.1159/000151695. Epub 2008 Aug 30.

PMID:
18758183
18.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
19.

Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.

Cipollone F, Ferri C, Desideri G, Paloscia L, Materazzo G, Mascellanti M, Fazia M, Iezzi A, Cuccurullo C, Pini B, Bucci M, Santucci A, Cuccurullo F, Mezzetti A.

Circulation. 2003 Dec 2;108(22):2776-82. Epub 2003 Nov 17.

PMID:
14623801
20.

Effects of interacting networks of cardiovascular risk genes on the risk of type 2 diabetes mellitus (the CODAM study).

van Greevenbroek MM, Zhang J, Kallen CJ, Schiffers PM, Feskens EJ, de Bruin TW.

BMC Med Genet. 2008 Apr 24;9:36. doi: 10.1186/1471-2350-9-36.

Supplemental Content

Support Center